Document is current

Any future updates will be listed below

Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America

Crossref DOI link: https://doi.org/10.1007/s10875-016-0327-9

Published Online: 2016-08-31

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark